Spain – Various medicinal products – Suministro de los medicamentos JEMPERLI 500mg/10ml per. IV (principio activo DOSTAR
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €390K to GLAXOSMITHKLINE, S.A. for Construction & Public Works in June 2024 — one of 94 awards this buyer has made, in line with its typical award size.
Winning supplier
GLAXOSMITHKLINE, S.A.Contract description
Spain – Various medicinal products – Suministro de los medicamentos JEMPERLI 500mg/10ml per. IV (principio activo DOSTARLIMAB); NUCALA 40mg jeringa precargada sc (principio activo MEPOLIZUMAB); HAVRIX 1440 jeringa precargada (vacuna hepatitis A); FENDRIX 20mcg adultos (vacuna hepatitis B, nefrópatas) y MENVEO 0,5ml vial (vacuna meningococo A.C.W.Y.)
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-696051-2024KERN PHARMA, S.L.€561K15 Nov 2024 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
Other wins · GLAXOSMITHKLINE, S.A.
149 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and GLAXOSMITHKLINE, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back